Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Four more time with the ten and nine weather forecast.
We got a little rain out there this morning. Things
are going to clear up. They say dry up by
dinner time or something. Anyway, Today's high eighty four overnight
and mostly cloudy night with the will of seventy two
eighty five to the high with mostly sunny skies. Tomorrow
clear over night sixty four, and on Thursday, mostly sunny
again with a high of eighty nine. Then it should
up that to seventy forty degrees. Right now, time for
(00:20):
final traffick Chuck Ingram from the UCU Transit Center.
Speaker 2 (00:23):
The University of Cincinnati Cancer Center hands the most comprehensive
blood cancer center in the nation. The future of cancer
care is here called five one, three, five, eight to
five U see see see North.
Speaker 1 (00:34):
Bend seventy five.
Speaker 2 (00:35):
It's an extra ten out of earline. You're slow again
at the lateral southbound heaviest through lock on with an
accidentated shepherd on the shoulder. Southbound seventy one break lights
between the Reagan Highway and Red Bank and East Bend
seventy four continues to be a slow go through Miami
Town thanks to problems earlier.
Speaker 1 (00:52):
Chuck Ingram on fifty five kr seed De Talk Station.
AY forty seven fifty fockkir se de talk station. It's
time to ask an expert. And my friends from OHC
have been in many times over the years offering information
about cancer, updated developments and treatments and protocols. They've taken
great care of me and my dealings and struggles with
(01:13):
cancer since I was diagnosed, and so I strongly encourage
you if you get a bad diagnosis. Sorry, I know
it sucks, but you got some great docs over at
OHC to help you out or get a second opinion.
It's eight eight eight six four ninety eight hundred eight
eight eight six four eight hundred. The website is ohcare
dot com. I'm happy to welcome to fifty five KRC
Morny Show Advance practice provider Kim Mullins, who are going
(01:38):
to move away from cancer and I this is crazy.
She's one of the providers at OHC caring for patients
and undergoing the revolutionary treatment, including what we're talking about today,
which is low dose radiation therapy for patients suffering from
osteo arthritis. Kim, good to have you on the program.
Speaker 3 (01:53):
Thank you. I'm glad to be here, and.
Speaker 1 (01:55):
I was telling you off air, I'm glad, I just
I was looking at an amazement. I didn't realize that
you could use radiation therapy to treat osteoarthritis.
Speaker 3 (02:03):
Right, right, most people don't.
Speaker 4 (02:07):
However, it's been done in Europe for probably over three decades,
so we have lots and lots of research that shows
this is a great alternative treatment.
Speaker 1 (02:18):
So what is low dose radiation visa osteorthritis? How does
it work? And let's let's dive on into what goes on?
Speaker 4 (02:26):
Okay, So most people are familiar with high doses of
radiation being used to treat cancer. Right, So radiation at
high doses can kill cells, which is our aim when
we want to kill cancer cells. However, we know that
it low doses, the radiation actually biologically does different things
(02:46):
and it decreases inflammation, so that's why we can use
it for osteoarthritis. So using low dose radiation for osteoarthritis
helps to decrease the inflammation, which as a result, then
we can see decreases in pain and increases in mobility
of those joints.
Speaker 1 (03:04):
Well, why has it taken so long for us to
embrace this therapy here in the United States. Do pharmaceutical
companies have something to do with it?
Speaker 4 (03:12):
He asked, Yeah, perhaps it does. Perhaps it does, But
regardless of why it's taken so long to get here, Yeah, yeah,
it's no problem.
Speaker 3 (03:25):
It's no problem.
Speaker 4 (03:27):
The benefit of us waiting a little bit longer is
actually twofold. One is since it's been done for so
many years in Europe and in particular in Germany, we
have really good research that we can base guidelines off of.
Speaker 1 (03:40):
Protocols are in place.
Speaker 4 (03:41):
Very much so, and we know that this is a
safe treatment, and we have years and years of experience
with patients who have had it, and so we have
long term information now to know it really is safe
and it's an effective treatment.
Speaker 3 (03:55):
So that's one of the benefits.
Speaker 4 (03:56):
And the other benefit is that you know, the technology
has evol during that time, and so our radiation machines
that we deliver the radiation from are very, very highly
technical and very precise with how we deliver the radiation.
Speaker 1 (04:11):
Uh, you said effective. What kind of success rate are
we talking about here for folks struggling with the osteoarthritis.
Speaker 3 (04:17):
Yeah, So.
Speaker 4 (04:20):
In general, the consensus is anywhere from seventy to seventy
five percent, well receive some kind of bitefit.
Speaker 1 (04:28):
WHOA. That is really impressive. It is, and it comes
along without the side effects of the pharmaceuticals that a
lot of people are taking, which I hear are can
be really really problematic when it comes to this.
Speaker 4 (04:39):
Sometimes Yeah, you know, situations vary, but the lotus radiation
really has an incredible side effect profile in that it's
pretty much zero.
Speaker 3 (04:49):
So there have been lots of studies.
Speaker 4 (04:51):
I know, I know what kind of treatment has zero,
but this in particular does, and it has to do
with the fact that it's just such a low dose
of radiation that has an effect on the body that
just decreases inflammation. So there have been some studies that
have shown maybe like one in a thousand people might
get a little bit of skin redness, but honestly, that's
(05:15):
not the norm. So the side effect profile is very
low skin redness versus dealing with the pain of osteoarthritis,
you know, And you're not even guaranteed the skin redness.
Speaker 1 (05:26):
Seventy five percent success rate, Yes, you're gonna have phone
ringing off the hook today. So I guess who's eligible
for this? In terms of you know, patient profile category,
because there's lot of people out there going listen, going.
Speaker 3 (05:39):
I got a call, I'm gonna call right, Right, that's
a good question.
Speaker 4 (05:43):
So there are one in seven people in the United
States that have arthritis that have osteoarthritis. Right.
Speaker 3 (05:49):
This affects a lot of people.
Speaker 4 (05:52):
Our patient profile looks like patients who are fifty and
older who have diagnosed osteoarthritis. The joints that we can
treat include the feet and the ankles, the knees, the hips, shoulders,
hands and wrists, and spine. So this is a lot
of joints that sure is that we can treat, right,
(06:14):
and a lot of the patients have tried several different
means of treatment. They've tried non steroidal drugs, they've tried
physical therapy, bracing any number of things, joint injections with
cordico steroids or with the gel that.
Speaker 3 (06:30):
They can inject.
Speaker 4 (06:31):
None of those preclude the patients from having low dose
radiation therapy and it won't actually interfere with any of
those future treatments. But there are also a number of
patients who either want to delay having surgery or they
cannot have surgery. For one reason or another, and this
is a wonderful alternative in those situations.
Speaker 1 (06:51):
So what does the treatment entail over what period of time?
I'm sure one dose of this low dose radiation is
not going to cut it. You're gonna have to have multiple.
So what's the story. If someone walks in and they're
eligible for the treatment, they fit the right profile, what
should they expect.
Speaker 3 (07:05):
So we'll meet with you first, of course, right, So
we'll do.
Speaker 4 (07:09):
Our consult and then the next step is to do
some mapping.
Speaker 3 (07:12):
So we want to be very.
Speaker 4 (07:14):
Precise with where we deliver the radiation. We do that
by CT guided imaging and so there's a cat skin
that's involved, but there's no die so it's very simple.
And for those who you know are concerned about being
in the tube, this is not in the tube test.
Speaker 3 (07:28):
That's an MRI. So the CT is much much easier
to tolerate.
Speaker 4 (07:32):
So we get a CT and then we do the
planning the patients come back. It involves generally six to
eight treatments. The treatments are about ten to fifteen minutes.
They are separated by at least a day, so two
to three treatments a week until those six or eight
treatments are received. Patients don't feel anything during the treatment.
(07:53):
The radiation is like a high powered X ray, so
you don't feel it or see it. It won't interfere
with any medications that they're doing, no activities that they
normally do. So they come and they get the treatment,
they get up, and they go on their way.
Speaker 1 (08:06):
Well, my executive producer wanted to know if insurance might
cover this.
Speaker 3 (08:10):
Yes, actually it does.
Speaker 1 (08:11):
Oh, good news, Joseph. I think he's calling you guys
right now.
Speaker 4 (08:15):
Okay, Medicare covers it, and then most insurances tend to
follow suit. And that's what's happened in this situation.
Speaker 1 (08:22):
Well, that's wonderful news. And how after the battery of
treatments is over, is that when the patients can expect
to feel the relief from the pain.
Speaker 4 (08:32):
Yes, in some cases, there are actually some situations where
about halfway through or towards the latter half of the
treatment that patients will actually start to notice some difference.
Speaker 3 (08:42):
But yeah, you're right.
Speaker 4 (08:43):
Generally afterwards is when patients start to notice the bulk
of the benefit. And that benefit can last from several
months up into a year and sometimes longer and.
Speaker 1 (08:53):
You're always there to get another round of treatments down
the road. Well, that is absolutely wonderful. Now, how is
it that my cancer doctor friends ended up providing this
particular therapy. It's it's not cancer related, it's osteo arthritis.
Speaker 4 (09:07):
Right right, Well, you know, at OHC, we have the
technology to provide these treatments, and obviously the research that's
coming out of Europe and Germany is just it's so
incredible the benefit that this can have. And so you know,
it's our mission to provide the best quality care that
we can to our community. That includes cancer patients, but
(09:29):
it also includes being able to use the technology we
already have in place to treat other conditions that are benign.
Speaker 1 (09:35):
It makes perfect sense. And obviously, with one in seven
Americans struggling with this is a huge demand out there
for relief. Well, this has been a rosy rosy discussion.
You're you on with your OHC. We're talking about cancer
and then we're talking about clinical trials, we're talking about
you know, survival rates. This is just all across the
board positive information. So folks out there osteoarthritis turned my
(09:55):
friends at OHC the number ready eight eight eight six
four nine four forty eight hundred eight eight eight six
four nine forty eight hundred online again Ohcare dot Com.
Kim Mollins, it has been a pleasure meeting and talking
with you about this my pleasure. Keep up the great work. Hey,
fifty six to fifty five krsd talk station dav get
a chance to listen live. V Vague Ramaswami joined the
(10:17):
program today the next government the state of Ohio. Check
out the podcast. Fifty five krsee dot com Inside Scoop
with Bright Barton News, Bradley Jay on the Big Beautiful
Bill and finally Daniel Davis Deep Dive Russia, Ukraine, Iran
and Israel. All there fifty five krs dot com Tune
tomorrow for Judge Jenna Paulaitano, have a wonderful day and
thank you Joe Strecker, who's on the phone right now
with OHC Folks. Stick around. Glenn Beck's coming right up
(10:38):
to say no to the neten yall who Trump will
and on another updates at the top of the hour.
Speaker 4 (10:45):
This cannot continue.
Speaker 1 (10:47):
Fifty five krz the talk station. This